Earlier studies have similarly found that severe patients, upon admission, show a greater frequency of AST increase compared with ALT.15,16 Other studies also report that AST levels differ the most between severe and non-severe groups.17 This contradicts other studies that found that ALT levels were significantly higher than AST levels in patients with severe COVID-19.18,19. This evidence concerns the gene GPT and COVID-19.